Reg i onal Cerebral Blood Flow Measurements i n Stroke: The Necess i ty of a Tomograph i c Approach Clinical use of cerebral blood flow (CBF) mea surements started soon after Kety and Schmidt (1945) devised the nitrous oxide method, the first theoretically sound method applicable to studies in man. A reduced mean CBF was found in stroke patients, reflecting mainly the flow in the nonin farcted tissue (Linden, 1955 ). This appears to indi cate a reduced energy metabolism and points to a reduced overall neuronal activity level in the entire brain after a stroke.
Subsequent years saw the development of meth ods based on the use of gamma-emitting isotopes, which were detected over the head by multiple scintillation probes or a single-crystal gamma cam era. Xenon-l33 administered by intracarotid injec tion or by inhalation is widely used, and a certain regionality in CBF recording can be obtained-in particular with regard to blood flow in the cortex over the convexity of the hemispheres. This ap proach has allowed us to see specific cortical re gions at work as reflected in an increase in flow and metabolism (Lassen et aI., 1978) . It also enables one to see localized CBF increases in cortical epilepsy (Hougaard et aI., 1976) . But, with regard to stroke, flow in a focal area cannot be adequately recorded with such methods. In the situation where the lesion has zero blood flow this is obviously so. Consider the problem of an infarct due to arterial occlusion and without collaterals or a hematoma: in this situ ation no isotope enters the lesion. Obviously one cannot then record a clearance curve from it. In the case of a much reduced but not zero flow, the same difficulty is present in principle-the small amount of isotope entering the lesion being "hidden" be hind radiation from other parts within the field of vision or scattered from other regions. It is as if one "looks through" the practically unlabeled infarct! hematoma (Donley et aI., 1975) . This dilemma is inherent in all the clearance methods, since they are based on curve shape (slope in a log system or height!area ratio) and not on the absolute counting rate. Consider again the totally ischemic area or the hematoma: even if the counts recorded stem from 141 other areas, the absolute counting rate must be de creased.
Without further arguing the point, it can be stated that only a tomographic approach that measures the amount of indicator in each area can effectively avoid the "look-through phenomenon" (Celsis et aI., 1981) .
Three atraumatic tomographic methods are cur rently being developed:
1. The krypton-77 clearance method (Yamamoto et al., 1979) . This method is based on costly posi tron emission technology and can be applied to other positron-emitting inert gases. Due to the necessity for making repeated scans with a short interval, the counting rate obtained is probably too low to allow the maximal spatial resolutio' n that the detector may yield. Using other positron-emitting tracers such as oxygen-15-labeled CO2, a blood flow-related scan may be recorded over a longer time interval, thus improving the spatial resolution.
2. The xenon-133 clearance method (Stokely et aI., 1980) . This is based on using a fast-rotating, sensitive (four cameras), single-photon-emission tomograph. The spatial resolution reached is lim ited, not only by low counting rate in the repeated scans, but also by Compton scattering effects. The use of other freely diffusible indicators such as xenon-l27 or an iodine-l23 labeled amphetamine compound as suggested by Winchell et aI. (1980) may prove advantageous.
3. The stable-xenon method based on enhance ment of conventional x-ray tomography (Drayer et aI., 1978) . This method suffers the disadvantage of an unfavorable signal-to-noise ratio due to the very slight enhancement obtainable. Other indicators have been proposed without, however, solving this basic problem, which is related to the problem of loading the brain tissue with a high concentration of atomic nuclei of high atomic weight.
Wider use of these methods in stroke cases is needed before their clinical value and the cost benefit relationship can be assessed. It is already 142 EDITORIAL clear, however, that the conventional x-ray tomo graphic technique will be recognized as merely con veying a "shadow of the truth" in the specific sense that a normal computed tomography image of an area does not rule out a critically reduced CBF in that same area (Lassen et aI., 1981) . Evidently a reduced flow may be inadequate for supplying enough oxygen for sustaining normal function and yet suffice for maintenance of the structure of the tissue to a degree that normal x-ray absorbance is preserved. Many urgent clinical problems in stroke management and in the management of sub arachnoidal hemorrhage will probably b�nefit from the new techniques-in particular the microsurgical approach to the improvement of focal blood flow. This is a major stimulus for pressing ahead with tomographic CBF methods that may break the magical barrier from clinical research to clinical usefulness. Niels A. Lassen
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